Booster jabs lower COVID-19 infection risk more than 10 fold for over 60s in Israel

Publicly released:
International

In people over 60, the rates of confirmed Covid-19 and severe illness were substantially lower after a booster (third) dose of the Pfizer vaccine than after two doses, new data from Israel shows. The study looked at more than 1 million people over 60 years of age who had been fully vaccinated with the Pfizer vaccine at least five months earlier. The study found that 12 days after the booster dose, the rate of infection was 11 times lower in the booster group than in the non-booster group. The rate of severe illness was almost 20 times lower in the booster group.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
New England Journal of Medicine
Research:Paper
Organisation/s: Weizmann Institute of Science, Technion–Israel Institute of Technology, Israel
Funder: Not available
Media Contact/s
Contact details are only visible to registered journalists.